Albert Koong, MD, PhD, becomes the new Chief Scientific Officer at UT MD Anderson Cancer Center.
Key Details
- 1Albert Koong, MD, PhD, formally appointed as UT MD Anderson's Chief Scientific Officer effective June 1, 2026.
- 2Previously served as interim CSO since January 1, 2026.
- 3Role includes overseeing laboratory and clinical research, fostering innovation, and supporting AI-driven scientific advancement.
- 4Has led as division head of Radiation Oncology and contributed significantly to GI radiation oncology research.
- 5Recognized with honors such as Fellow of the American College of Radiology (FACR) and American Society for Radiation Oncology (FASTRO).
Why It Matters
Leadership at a prominent cancer center, especially with expertise in radiation oncology and ties to AI advancement, influences radiology and imaging research directions and collaborations. This appointment further signals ongoing integration of AI in cancer science by institutional leaders.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Analysis Predicts Immunotherapy Response in Rare Tumors
AI-based analysis of tumor pathology slides can predict immunotherapy outcomes in rare cancers, according to a recent MD Anderson study.
•EurekAlert
Review Highlights AI's Impact on Breast Cancer Imaging and Recurrence Prediction
A major review details how AI enhances early detection and recurrence prediction in breast cancer imaging.
•EurekAlert
Sleep as a Model for Neural Network Resilience in Brains and AI
A new review proposes sleep as a critical resilience mechanism in biological brains and artificial neural networks, with implications for catastrophic forgetting in AI.